Machine learning identifies proteomic risk factors across 23 diseasesShow others and affiliations
2026 (English)In: iScience, E-ISSN 2589-0042, Vol. 29, no 2, article id 114687Article in journal (Refereed) Published
Abstract [en]
Achieving minimally invasive and rapid detection is a crucial goal in modern medicine. The comprehensive characterization of the blood proteome holds great promise in advancing our understanding of disease etiology, facilitating early diagnosis, risk stratification, and improved monitoring across various diseases and their subtypes. In this study, we collected plasma proteomes from over 3000 patients, representing 23 distinct diseases, encompassing a total of 1462 proteins. Based on histological knowledge, we developed a two-stage hierarchical multi-disease classifier and applied it to perform multi-disease classification on the collected proteomic data. Our results demonstrate that this empirically guided two-stage hierarchical multi-disease classifier outperforms traditional machine learning algorithms in terms of prediction performance, showing better balance and more meaningful feature selections. This finding highlights the positive role that domain expertise can play in machine learning-based disease detection, and underscores the potential of plasma proteomics for multi-disease screening.
Place, publisher, year, edition, pages
Elsevier BV , 2026. Vol. 29, no 2, article id 114687
Keywords [en]
machine learning, medicine, proteomics
National Category
Basic Medicine
Identifiers
URN: urn:nbn:se:kth:diva-377158DOI: 10.1016/j.isci.2026.114687ISI: 001679587600001PubMedID: 41660256Scopus ID: 2-s2.0-105028660136OAI: oai:DiVA.org:kth-377158DiVA, id: diva2:2041628
Note
QC 20260225
2026-02-252026-02-252026-02-25Bibliographically approved